Healthcare

Pharmaceuticals Medical Devices Health Insurance Pharmaceutical Industry Healthcare Companies Biotechnology Insurance Medical Technology Healthcare Services Healthcare Providers

Inspire Medical Investors Urged to Act as Jan. 5 Lead‑Plaintiff Deadline Nears in Inspire V Securities Case

The lawsuit is pending in Minnesota federal court, centering on claims that Inspire concealed operational problems with the Inspire V rollout.

Canopy Growth Jumps as Reports Say Trump May Pursue Federal Cannabis Rescheduling

HSBC Upgrades AbbVie to Buy, Lifts Target to $265 as Skyrizi and Rinvoq Drive Growth

Zealand Pharma Unveils ‘Metabolic Frontier 2030’ With Targets for Five Launches

CVS Lifts 2025 Outlook, Sets 2026 Targets and Unveils AI Consumer Platform

Teleflex To Divest Acute Care, Interventional Urology and OEM Units for $2.03 Billion

CMS Picks CLEAR to Modernize Medicare.gov Identity Verification Starting in 2026

FDA Meeting Minutes Undercut uniQure’s Plan to File Huntington’s Gene Therapy for Approval

Philips Reaffirms February Date for 2026 Outlook as Stock Slides on CEO Caution

CHS Finalizes $194 Million Sale of Outreach Lab Assets to Labcorp

Bristol Myers Delays ADEPT-2 Alzheimer’s Psychosis Readout to 2026 After Site Irregularities

MoonLake Investors Face Dec. 15 Lead-Plaintiff Deadline in Securities Class Action

Inspire Medical Investors Get Jan. 5 Deadline Reminder in Securities Suit Over Inspire V Rollout

Bristol Myers and J&J Cast as Dividend Plays as Bayer’s FXIa Win Refocuses Pipeline Interest

MPM BioImpact Exits MBX, MoonLake, Crinetics in Q3, SEC Filing Shows

aTyr Investors Face Dec. 8 Deadline as Rival Lawsuits Over Failed Sarcoidosis Trial Intensify

Inspire Medical Investors Face Jan. 5 Lead-Plaintiff Deadline in Suit Over Inspire V Rollout

Novo Nordisk Files for 7.2 mg Wegovy Dose After Stronger Weight-Loss Results

Eli Lilly Briefly Hits $1 Trillion as GLP-1 Boom Spurs Fresh Analyst Targets

Embecta Beats Q4 EPS Expectations as Sales Miss and Debt Declines